Compare Devine Impex with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0.23%
- Poor long term growth as Net Sales has grown by an annual rate of 4.90% and Operating profit at 2.66% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.07
With ROE of 0.9, it has a Expensive valuation with a 0.6 Price to Book Value
Underperformed the market in the last 1 year
Stock DNA
Trading & Distributors
INR 8 Cr (Micro Cap)
68.00
55
0.00%
0.00
0.88%
0.59
Total Returns (Price + Dividend) 
Devine Impex for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Devine Impex Ltd Falls to 52-Week Low of Rs 7.38 as Sell-Off Deepens
For the fifth consecutive session, Devine Impex Ltd closed lower, slipping to a fresh 52-week low of Rs 7.38 on 15 Apr 2026. This decline comes despite a broader market rally, with the Sensex advancing 1.74% on the same day.
Read full news article
Devine Impex Ltd Falls to 52-Week Low of Rs 7.39 as Sell-Off Deepens
For the fifth consecutive session, Devine Impex Ltd closed lower, slipping to a fresh 52-week low of Rs 7.39 on 6 Apr 2026. This decline comes despite a broader market rally, highlighting stock-specific pressures that have weighed heavily on the micro-cap trading and distribution company.
Read full news article Announcements 
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
13-Apr-2026 | Source : BSESubmission of certificate under Reg 74(5) of DP Regulations 2018
Closure of Trading Window
31-Mar-2026 | Source : BSEClosure of Trading window Intimation
Announcement under Regulation 30 (LODR)-Newspaper Publication
13-Feb-2026 | Source : BSESubmission of Newspaper publication
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 1 Schemes (0.02%)
Held by 0 FIIs
Manju Jain (13.11%)
Synergy Cosmetics (exim) Limited (7.76%)
17.92%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 24.32% vs 208.33% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 233.33% vs 400.00% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -31.51% vs 52.08% in Sep 2024
Growth in half year ended Sep 2025 is 0.00% vs 166.67% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -10.28% vs 48.61% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 200.00% vs 100.00% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 13.64% vs -1.12% in Mar 2024
YoY Growth in year ended Mar 2025 is -25.00% vs -20.00% in Mar 2024







